This is the authors' abstract. We don't add key points for this paper.
This study consolidates disease-free interval, synchronous presentation, and number and size of lesions as clinically relevant data that may help guide therapy for patients with colorectal cancer and lung metastases who are candidates for curative-intent metastasectomy. Additionally, in this sample, lack of cytokeratin 20 expression in metastases was associated with shorter progression-free survival and overall survival, suggesting that biomarkers also may have a role in guiding therapy in this setting and that additional biomarkers should be further explored.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Gössling et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: